Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?-Reference-Cited by-同舟云学术

Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

Published:2023-09 Issue: Volume:386 Page:59-64
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Melendo-Viu Maria,Dobarro David,Marchán López Álvaro,Domínguez Luis Manuel,Raposeiras-Roubín Sergio,Abu-Assi Emad,Cardero-González Carmen,Pérez-Expósito Lucía,Cespón Fernández María,Parada Barcia Jose Antonio,Barreiro Pérez Manuel,García Enrique,Íñiguez Romo Andrés

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Estimated population prevalence of heart failure with reduced ejection fraction in Spain, according to DAPA-HF study criteria;Camps-Vilaró;J. Clin. Med.,2020

3. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

4. Treatment of HF in an era of multiple therapies: statement from the HF Collaboratory;Bhatt;JACC Heart Fail.,2021

5. Heart failure patients with low blood pressure;Parwani;Circ. Heart Fail.,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantage of uptitration of foundational heart failure drugs in heart failure with reduced ejection fraction and low blood pressure;European Journal of Heart Failure;2024-01-25

2. Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going;International Journal of Cardiology;2023-10